Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
08/2011
08/11/2011US20110196161 Method for preparing dianhydrohexitol diester compositions
08/11/2011US20110195940 Protease Inhibitors Having Enhanced Features
08/11/2011US20110195842 2,4,6-Phenyl-Substituted Cyclic Ketoenols
08/10/2011EP2354175A1 Method for storing dihydroxy compound to be used as starting material for polycarbonate, method for preparing starting material for polycarbonate and method for producing polycarbonate
08/10/2011EP2114952B1 Mixture of diesters of dianhydrohexitol derivatives with carboxylic acids of the empirical formula C8H17COOH, processes for preparing these diesters and use of these mixtures
08/10/2011CN102149717A Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
08/10/2011CN102146086A Preparation method of sodium cantharidate
08/10/2011CN102146085A 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
08/10/2011CN101050445B Microbe for producing epothilone
08/09/2011US7994215 High purity phthalein derivatives and method for preparing same
08/09/2011US7994093 Heterocyclocarboxamide derivatives
08/04/2011WO2011094339A1 Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs
08/04/2011WO2011093187A1 Method for producing pyripyropene derivative by enzymatic process
08/04/2011WO2011092687A1 Process for the preparation of darunavir and darunavir intermediates
08/04/2011US20110190323 Cortistatin analogues and syntheses thereof
08/04/2011US20110186777 Polymerizable chiral compound, polymerizable liquid crystal composition, liquid crystal polymer and optically anisotropic body
08/04/2011CA2787919A1 Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs
08/04/2011CA2787829A1 Method for producing pyripyropene derivatives by the enzymatic method
08/04/2011CA2784398A1 Process for the preparation of darunavir and darunavir intermediates
08/03/2011EP2350034A1 Novel herbicides
08/03/2011CN102140101A Method for preparing Herperione, application thereof, capsule thereof, preparation method and application of capsule
08/03/2011CN101213198B 1-[2',3'-dideoxy-3'C-(hydroxymethyl)-beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors
08/03/2011CN101184756B Isoflavonoid dimers
08/02/2011US7989491 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
08/02/2011CA2667966C Pyrazoline compounds as mineralocorticoid receptor antagonists
08/02/2011CA2497119C A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
08/02/2011CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/02/2011CA2442870C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
07/2011
07/28/2011WO2011089507A1 A new series of artemisinin derivatives and process for preparation thereof
07/28/2011US20110184193 Process for producing spiroglycol
07/28/2011US20110184192 Prostaglandin synthesis and intermediates for use therein
07/28/2011US20110184190 Compounds useful in the synthesis of halichondrin b analogs
07/28/2011CA2787722A1 A new series of artemisinin derivatives and process for preparation thereof
07/27/2011EP2348025A1 Nfat signal inhibitor and hair-growing agent
07/27/2011EP2346877A1 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b]furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl](isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
07/27/2011EP2346876A1 Novel 4beta-amino podophvllotoxin congeners as anti tumour antibiotics a process for the preparation thereof
07/27/2011EP2346844A1 Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders
07/27/2011CN102134247A Xanthotoxol derivative and new composite method thereof
07/27/2011CN102134246A Epothilone derivatives as well as preparation and medicament application thereof
07/27/2011CN101774989B Method for extracting refined yellow pigment from red flowers
07/27/2011CN101648957B Preparation method of sesamin phenol
07/27/2011CN101481378B 2,3,6,7-tetracarboxylic dianhydride triptycene and method for synthesizing the same
07/26/2011CA2360452C C-21 modified epothilones
07/21/2011WO2011088303A1 Inhibitors of flaviviridae viruses
07/21/2011WO2011087000A1 Diagnostic for cancer
07/21/2011WO2011086873A1 Organic electroluminescent element and light-emitting polymer composition
07/21/2011WO2011085544A1 Compounds which effecttively remove tumor or cancer cell
07/21/2011US20110178200 Reactive mesogenic compounds and mixtures
07/21/2011US20110178098 Anticancer compounds and methods of making and using same
07/21/2011US20110178058 Inhibitors of flaviviridae viruses
07/21/2011US20110178050 Use of cyclolignans for the treatment of a hyperactive immune system
07/21/2011CA2785563A1 Inhibitors of flaviviridae viruses
07/20/2011EP1786820B1 9-(1',5'-dimethyl-1'-vinyl-4'-hexenyl)-4-hydroxy-7h-furo[3,2-g][1]benzopyran-7-one as antibacterial agent
07/20/2011EP1451195B1 3-biphenyl-substituted-3-substituted-4-ketolactams and ketolactones and their utilization as pesticide
07/20/2011CN102131815A Process for preparation of (3r, 3as, 6ar)-hexahydrofuro [2, 3-b] furan-3-yl (1s, 2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
07/20/2011CN102131814A New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, process for preparing them, and application thereof in therapy as anticancer agents
07/20/2011CN102127090A Method for extracting tulip tree resinol B from Chinese Stellera root
07/20/2011CN101735235B Compound for preventing amyloid-beta peptide aggregation, and preparation method and application thereof
07/20/2011CN101525338B Water soluble oridonin derivative and preparation method thereof
07/19/2011US7982059 Sorbitol conversion process
07/19/2011US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
07/19/2011US7981443 Administration of therapeutically effective amount of topiramate over sleep period of patient
07/14/2011WO2011083287A2 Darunavir polymorph and process for preparation thereof
07/14/2011WO2011051978A3 A novel process for preparation of darunavir and darunavir ethanolate of fine particle size
07/14/2011WO2011025271A3 Metformin ascorbate, method for preparing same, pharmaceutical composition comprising same, and combined formulation comprising same
07/14/2011US20110172446 Methods and compositions for use in treating cancer
07/14/2011US20110172257 (poly) aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents
07/14/2011CA2785998A1 Darunavir polymorph and process for preparation thereof
07/13/2011EP2343301A1 Anionic isosorbide derivatives and their use (II)
07/13/2011EP2343300A1 Anionic isosorbide derivatives and their use (II)
07/13/2011EP1539717B1 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
07/13/2011EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/13/2011CN102124010A Isosorbide nitrates having vasodilating activity
07/13/2011CN102120743A Novel anti-tumor epoxy-containing eremophilane sesquiterpene lactone
07/13/2011CN102120737A Baicalein derivatives and preparation method and application thereof
07/12/2011US7977466 C-glycoside derivatives and salts thereof
07/12/2011US7977322 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders
07/07/2011WO2011082354A2 Thiol detection
07/07/2011US20110166297 MOLECULARLY IMPRINTED SMART POLYMERS (MISPs)
07/07/2011US20110165633 Production of Polyketides and Other Natural Products
07/07/2011US20110165225 Modified Drugs for Use in Liposomal Nanoparticles
07/07/2011US20110163267 Chiral compounds and liquid crystal compositions and polymer networks derived therefrom
07/06/2011EP2341058A2 Oligonucleotide Analogues
07/06/2011EP2341057A2 Oligonucleotide Analogues
07/06/2011EP2340244A1 Compounds and methods of use
07/06/2011EP1643984B1 Use of parthenolide derivatives as antileukemic and cytotoxic agents
07/06/2011CN1882593B Fused pentacyclic polyethers
07/06/2011CN1705662B Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
07/06/2011CN102115477A Preparation method of 2',2'-dimethyl-pyran-[5',6':7,8]flavone
07/06/2011CN101190920B Method for preparing 3-dibutylamino-6-methyl-7-anilinfluorane
07/05/2011CA2217745C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/2011
06/30/2011WO2011048148A3 Glycoside derivative and uses thereof
06/30/2011WO2010089171A3 Method for the amination of polycyclic compounds using transaminases
06/30/2011US20110160468 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
06/29/2011EP2337782A1 Anti-tumor activity of aechl-i, a novel triterpenoid isolated from ailanthus excelsa in vitro and in vivo
06/29/2011CN102112481A Process for producing carnosol from carnosic acid using hydrogen peroxide or peracids
06/29/2011CN102112447A HIV integrase inhibitors from pyridoxine
06/29/2011CN102108083A Polycyclic benzopyrone compounds and preparation method and application thereof
06/28/2011CA2467672C Chemokine receptor antagonists and methods of use therefor
06/23/2011WO2011074232A1 Polycyclic ring-fused compound and organic thin film transistor utilizing same
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 174